Project

A 4 Month, open label, multi-center study to explore the tolerability and safety and health outcomes of FTY720 in patients with relapsong forms of multiple sclerosis

Completed · 2010 until 2011

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2010
End Date
2011
Financing
Industry
Brief description/objective

A 4 Month, open label, multi-center study to explore the tolerability and safety and health outcomes of FTY720 in patients with relapsong forms of multiple sclerosis

Study: FTY720 - 2316